Invention Grant
- Patent Title: Bispecific heterodimeric diabodies and uses thereof
-
Application No.: US14751704Application Date: 2015-06-26
-
Publication No.: US09884921B2Publication Date: 2018-02-06
- Inventor: Chad Michael May , Adam Reid Root , William A. Brady , Lioudmila Gennadievna Tchistiakova , Lidia Mosyak , Laird Bloom , Paul A. Moore , Leslie S. Johnson
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Maria V. Marucci
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/46 ; C07K16/18
Abstract:
Bispecific heterodimeric diabody molecules and uses thereof in the treatment of cancer. The bispecific heterodimeric diabody molecules comprise two polypeptide chains that associate to form two epitope binding sites recognizing the P-cadherin tumor cell associated antigen and the CD3 T cell antigen.
Public/Granted literature
- US20160002357A1 BISPECIFIC HETERODIMERIC DIABODIES AND USES THEREOF Public/Granted day:2016-01-07
Information query
